Clade Therapeutics pursues universal cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

Clade ¬†Therapeutics has been pursuing the idea of using gene-editing to make universally compatible cells. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients without fear of immune rejection? Clade Therapeutics Boston Business Journal covers the …

Clade Therapeutics pursues universal cells for cancer therapy Read More »